Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.

CGAS is a micronucleophagy receptor for the clearance of micronuclei

Open access

Abstract

Micronuclei are constantly considered as a marker of genome instability and very recently found to be a trigger of innate immune responses. An increased frequency of micronuclei is associated with many diseases, but the mechanism underlying the regulation of micronuclei homeostasis remains largely unknown. Here, we report that CGAS (cyclic GMP-AMP synthase), a known regulator of DNA sensing and DNA repair, reduces the abundance of micronuclei under genotoxic stress in an autophagy-dependent manner. CGAS accumulates in the autophagic machinery and directly interacts with MAP1LC3B/LC3B in a manner dependent upon its MAP1LC3-interacting region (LIR). Importantly, the interaction is essential for MAP1LC3 recruitment to micronuclei and subsequent clearance of micronuclei via autophagy (micronucleophagy) in response to genotoxic stress. Moreover, in contrast to its DNA sensing function to activate micronuclei-driven inflammation, CGAS-mediated micronucleophagy blunts the production of cyclic GMP-AMP (cGAMP) induced by genotoxic stress. We therefore conclude that CGAS is a receptor for the selective autophagic clearance of micronuclei and uncovered an unprecedented role of CGAS in micronuclei homeostasis to dampen innate immune surveillance.Abbreviations: ATG: autophagy-related; CGAS: cyclic GMP-AMP synthase; CQ: chloroquine; GABARAP: GABA type A receptor-associated protein; GFP: green fluorescent protein; LAMP1: lysosomal associated membrane protein 1; LAMP2: lysosomal associated membrane protein 2; LIR, MAP1LC3-interacting region; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; NDZ: nocodazole; STING1: stimulator of interferon response cGAMP interactor 1

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15548627.2021.1899440

Cites

99 of 99 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. CGAS reduced the abundance of micronuclei. (A and B) Immunofluorescence assay showing the micronuclei in HEK293 cells stably transfected with GFP and GFP-CGAS in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery (A). The quantification data were shown in (B). (C) Immunoblot of the lysates of U2OS cells stably transfected with control gRNA or gRNA targeting CGAS. (D and E) Immunofluorescence assay showing the micronuclei in WT and CGAS−/- U2OS cells in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery (D). The quantification data were shown in (E). (F and G) Representative flow cytometry analysis of the micronuclei in reticulocytes isolated from WT and cgas−/- mouse left untreated or treated with NDZ at a dose of 5 mg/kg intraperitoneally for 24 h (F). The quantification data were shown in (G). Data are expressed as mean ± (SEM) of 3 independent experiments (B, E, G). n = 3 independent experiments (A, C, D, F). Nuclei were stained with DAPI (blue). One-way ANOVA with Bonferroni post hoc test were used for statistical analysis. Scale bar: 10 μm
Figure 1. CGAS reduced the abundance of micronuclei. (A and B) Immunofluorescence assay showing the micronuclei in HEK293 cells stably transfected with GFP and GFP-CGAS in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery (A). The quantification data were shown in (B). (C) Immunoblot of the lysates of U2OS cells stably transfected with control gRNA or gRNA targeting CGAS. (D and E) Immunofluorescence assay showing the micronuclei in WT and CGAS−/- U2OS cells in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery (D). The quantification data were shown in (E). (F and G) Representative flow cytometry analysis of the micronuclei in reticulocytes isolated from WT and cgas−/- mouse left untreated or treated with NDZ at a dose of 5 mg/kg intraperitoneally for 24 h (F). The quantification data were shown in (G). Data are expressed as mean ± (SEM) of 3 independent experiments (B, E, G). n = 3 independent experiments (A, C, D, F). Nuclei were stained with DAPI (blue). One-way ANOVA with Bonferroni post hoc test were used for statistical analysis. Scale bar: 10 μmCC BY-NC-ND · PubMed Central
Figure 2. CGAS interacted with LC3B. (A) Prediction of LIRs in CGAS by iLIR and protein sequence alignments of conserved LIR motifs. (B) Immunoblot of cell lysates or anti-Flag immunoprecipitates from HEK293 cells that had been transfected with Flag-LC3B and GFP-CGAS. (C) Results of in vitro precipitation assay with anti-His antibody and protein agarose of His-tagged LC3B and SUMO-tagged CGAS. (D) Binding curves of surface-immobilized SUMO-tagged CGAS with His-tagged LC3B at concentrations of 800 nM, 400 nM, 300 nM, 200 nM and 100 nM. Vertical lines mark the starts of association and dissociation phases of the binding events. The dashed lines are global fits to a Langmuir reaction model; global fitting parameters are listed in the table below the plot. (E) Immunoblot of cell lysates and anti-LC3B immunoprecipitates from U2OS cells in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 24-h recovery, and cells were left untreated or treated with CQ (40 μM) treatment 8 h prior to harvesting. (F and G) PLA showing the interaction of CGAS with LC3B in U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were cultured in the absence or presence of CQ (40 μM) for 12 h prior to harvesting (F). The quantification data were shown in (G). Data are representative of n = 3 independent experiments (B-F). Data are expressed as mean ± (SEM) of 3 independent experiments (G). Scale bar: 50 μm
Figure 2. CGAS interacted with LC3B. (A) Prediction of LIRs in CGAS by iLIR and protein sequence alignments of conserved LIR motifs. (B) Immunoblot of cell lysates or anti-Flag immunoprecipitates from HEK293 cells that had been transfected with Flag-LC3B and GFP-CGAS. (C) Results of in vitro precipitation assay with anti-His antibody and protein agarose of His-tagged LC3B and SUMO-tagged CGAS. (D) Binding curves of surface-immobilized SUMO-tagged CGAS with His-tagged LC3B at concentrations of 800 nM, 400 nM, 300 nM, 200 nM and 100 nM. Vertical lines mark the starts of association and dissociation phases of the binding events. The dashed lines are global fits to a Langmuir reaction model; global fitting parameters are listed in the table below the plot. (E) Immunoblot of cell lysates and anti-LC3B immunoprecipitates from U2OS cells in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 24-h recovery, and cells were left untreated or treated with CQ (40 μM) treatment 8 h prior to harvesting. (F and G) PLA showing the interaction of CGAS with LC3B in U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were cultured in the absence or presence of CQ (40 μM) for 12 h prior to harvesting (F). The quantification data were shown in (G). Data are representative of n = 3 independent experiments (B-F). Data are expressed as mean ± (SEM) of 3 independent experiments (G). Scale bar: 50 μmCC BY-NC-ND · PubMed Central
Figure 3. LIR domain of CGAS was required for CGAS-LC3 interaction. (A) Immunoblot of cell lysates and anti-Flag immunoprecipitates from HEK293 cells that had been stably transfected with Flag-LC3B and GFP-CGAS, GFP-CGASΔ355-360 or GFP-CGASF357A,V360A. (B) Results of in vitro precipitation assay with anti-His antibody and protein agarose of His-tagged LC3B and SUMO-tagged CGAS or SUMO-tagged CGASF357A,V360A. (C) Immunoblot of cell lysates and anti-LC3B immunoprecipitates from U2OS cells that had been stably transfected with GFP, GFP-CGAS, GFP-CGASΔ355-360 or GFP-CGASF357A,V360A in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery. Data are representative of n = 3 independent experiments
Figure 3. LIR domain of CGAS was required for CGAS-LC3 interaction. (A) Immunoblot of cell lysates and anti-Flag immunoprecipitates from HEK293 cells that had been stably transfected with Flag-LC3B and GFP-CGAS, GFP-CGASΔ355-360 or GFP-CGASF357A,V360A. (B) Results of in vitro precipitation assay with anti-His antibody and protein agarose of His-tagged LC3B and SUMO-tagged CGAS or SUMO-tagged CGASF357A,V360A. (C) Immunoblot of cell lysates and anti-LC3B immunoprecipitates from U2OS cells that had been stably transfected with GFP, GFP-CGAS, GFP-CGASΔ355-360 or GFP-CGASF357A,V360A in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery. Data are representative of n = 3 independent experimentsCC BY-NC-ND · PubMed Central
Figure 4. CGAS regulated the autophagy of micronuclei. (A) Immunofluorescence assay showing the colocalization of CGAS with LC3B at micronuclei in U2OS cells treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were left treated with CQ (40 μM) for 12 h prior to harvesting. DAPI, nuclei. (B) Immunogold electron microscopy showing the colocalization of CGAS with MN in autophagosome. The red arrow indicated CGAS. (C and D) PLA assay showing the colocalization of CGAS with LC3B at micronuclei in U2OS cells treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were cultured in the absence or presence of CQ (40 μM) for 12 h prior to harvesting (C). The quantification data was shown in (D). (E and F) Immunofluorescent assay showing LC3B and micronuclei of WT and CGAS−/- U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery (E). The quantification data was shown in (F). (G) Immunoblot of cell lysates and lysosomes purified from U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery. (H) Immunofluorescence assay showing the colocalization of CGAS with LC3B and LAMP2 at micronuclei in U2OS cells that had been stably transfected with GFP-CGAS left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery. DAPI, nuclei. (I and J) Immunofluorescent assay showing the staining of LC3B, LAMP2 and micronuclei of WT and CGAS−/- U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery (I). The quantification data is shown in (J). Data are expressed as mean ± (SEM) of 3 independent experiments (D, F, J). Data are representative of n = 3 independent experiments (A-C, E, G-I). Nuclei were stained with DAPI (blue). One-way ANOVA with Bonferroni post hoc test were used for statistical analysis. Scale bar: 2.5 μm (A and H), 10 μm (C and I), 200 nm (B)
Figure 4. CGAS regulated the autophagy of micronuclei. (A) Immunofluorescence assay showing the colocalization of CGAS with LC3B at micronuclei in U2OS cells treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were left treated with CQ (40 μM) for 12 h prior to harvesting. DAPI, nuclei. (B) Immunogold electron microscopy showing the colocalization of CGAS with MN in autophagosome. The red arrow indicated CGAS. (C and D) PLA assay showing the colocalization of CGAS with LC3B at micronuclei in U2OS cells treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were cultured in the absence or presence of CQ (40 μM) for 12 h prior to harvesting (C). The quantification data was shown in (D). (E and F) Immunofluorescent assay showing LC3B and micronuclei of WT and CGAS−/- U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery (E). The quantification data was shown in (F). (G) Immunoblot of cell lysates and lysosomes purified from U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery. (H) Immunofluorescence assay showing the colocalization of CGAS with LC3B and LAMP2 at micronuclei in U2OS cells that had been stably transfected with GFP-CGAS left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery. DAPI, nuclei. (I and J) Immunofluorescent assay showing the staining of LC3B, LAMP2 and micronuclei of WT and CGAS−/- U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery (I). The quantification data is shown in (J). Data are expressed as mean ± (SEM) of 3 independent experiments (D, F, J). Data are representative of n = 3 independent experiments (A-C, E, G-I). Nuclei were stained with DAPI (blue). One-way ANOVA with Bonferroni post hoc test were used for statistical analysis. Scale bar: 2.5 μm (A and H), 10 μm (C and I), 200 nm (B)CC BY-NC-ND · PubMed Central
Figure 5. CGAS promoted the clearance of micronuclei through autophagy. (A) Immunoblot of the lysates of U2OS cells stably transfected with control gRNA or gRNA targeting CGAS or ATG7 left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery. (B and C) Immunofluorescence assay showing the micronuclei in CGAS+/+ATG7+/+, CGAS−/-ATG7+/+, CGAS+/+ATG7−/- and CGAS−/-ATG7−/- U2OS cells in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery (B). The quantification was shown in (C). (D and E) Immunofluorescence assay showing the micronuclei in U2OS cells that had been transfected with GFP or GFP-CGAS in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery, and cells were left untreated or treated with CQ (40 μM) 8 h prior to harvesting (D). The quantification was shown in (E). Data are expressed as mean ± (SEM) of n = 3 independent experiments (C, E). Data are representative of n = 3 independent experiments (A, B, D). Nuclei were stained with DAPI (blue). Two-way ANOVA with Bonferroni post hoc test were used for statistical analysis. Scale bar: 10 μm
Figure 5. CGAS promoted the clearance of micronuclei through autophagy. (A) Immunoblot of the lysates of U2OS cells stably transfected with control gRNA or gRNA targeting CGAS or ATG7 left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery. (B and C) Immunofluorescence assay showing the micronuclei in CGAS+/+ATG7+/+, CGAS−/-ATG7+/+, CGAS+/+ATG7−/- and CGAS−/-ATG7−/- U2OS cells in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery (B). The quantification was shown in (C). (D and E) Immunofluorescence assay showing the micronuclei in U2OS cells that had been transfected with GFP or GFP-CGAS in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery, and cells were left untreated or treated with CQ (40 μM) 8 h prior to harvesting (D). The quantification was shown in (E). Data are expressed as mean ± (SEM) of n = 3 independent experiments (C, E). Data are representative of n = 3 independent experiments (A, B, D). Nuclei were stained with DAPI (blue). Two-way ANOVA with Bonferroni post hoc test were used for statistical analysis. Scale bar: 10 μmCC BY-NC-ND · PubMed Central
Figure 6. CGAS mediated the clearance of micronuclei as an autophagy receptor. (A) Immunoblot of cell lysates and lysosomes purified from U2OS cells that had been stably transfected with HA-CGAS or HA-CGASΔ355-360 in the absence or presence of NDZ (300 nM) treatment. (B-C), Immunofluorescence assay showing the micronuclei in CGAS−/- U2OS cells that had been transfected with GFP, GFP-CGAS, GFP- CGASΔ355-360 or GFP-CGASF357A,V360A in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery (B). The quantification is shown in (C). (D and E) Immunofluorescence assay showing the LC3B positive micronuclei in CGAS−/- U2OS cells that had been stably transfected with GFP, GFP-CGAS, GFP- CGASΔ355-360 or GFP-CGASF357A,V360A left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery (D). The quantification is shown in (E). Data are expressed as mean ± (SEM) of n = 3 independent experiments (C, E). Data are representative of n = 3 independent experiments (A, B, D). Nuclei were stained with DAPI (blue). Two-way ANOVA with Bonferroni post hoc test were used for statistical analysis. Scale bar: 10 μm
Figure 6. CGAS mediated the clearance of micronuclei as an autophagy receptor. (A) Immunoblot of cell lysates and lysosomes purified from U2OS cells that had been stably transfected with HA-CGAS or HA-CGASΔ355-360 in the absence or presence of NDZ (300 nM) treatment. (B-C), Immunofluorescence assay showing the micronuclei in CGAS−/- U2OS cells that had been transfected with GFP, GFP-CGAS, GFP- CGASΔ355-360 or GFP-CGASF357A,V360A in the absence or presence of NDZ (300 nM) treatment for 24 h followed by 48-h recovery (B). The quantification is shown in (C). (D and E) Immunofluorescence assay showing the LC3B positive micronuclei in CGAS−/- U2OS cells that had been stably transfected with GFP, GFP-CGAS, GFP- CGASΔ355-360 or GFP-CGASF357A,V360A left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery (D). The quantification is shown in (E). Data are expressed as mean ± (SEM) of n = 3 independent experiments (C, E). Data are representative of n = 3 independent experiments (A, B, D). Nuclei were stained with DAPI (blue). Two-way ANOVA with Bonferroni post hoc test were used for statistical analysis. Scale bar: 10 μmCC BY-NC-ND · PubMed Central
Figure 7. CGAS-mediated micronucleophagy impaired micronuclei-driven innate immunity. (A) qRT-PCR assay showing the induction of IFNB1 transcripts in HA-STING1 stable HEK293T cells transfected with indicated plasmids. (B) Results of in vitro precipitation assay showing the interaction of biotin-labeled ISD with SUMO-tagged CGAS or SUMO-tagged CGAS F357A,V360A. (C) Quantification of the abundance of cGAMP in U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were cultured in the absence or presence of CQ (40 μM) for 12 h prior to harvesting. (D) Quantification of the abundance of cGAMP level in CGAS−/- U2OS cells that had been stably transfected with GFP, GFP-CGAS, GFP-CGASΔ355-360 or GFP-CGASF357A,V360A, respectively, left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were cultured in the absence or presence of CQ (40 μM) for 12 h prior to harvesting. Data are expressed as mean ± (SEM) of n = 3 independent experiments (A, C, D). Data in (B) is representative of n = 3 independent experiments. Two-way ANOVA with Bonferroni post hoc test were used for statistical analysis
Figure 7. CGAS-mediated micronucleophagy impaired micronuclei-driven innate immunity. (A) qRT-PCR assay showing the induction of IFNB1 transcripts in HA-STING1 stable HEK293T cells transfected with indicated plasmids. (B) Results of in vitro precipitation assay showing the interaction of biotin-labeled ISD with SUMO-tagged CGAS or SUMO-tagged CGAS F357A,V360A. (C) Quantification of the abundance of cGAMP in U2OS cells left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were cultured in the absence or presence of CQ (40 μM) for 12 h prior to harvesting. (D) Quantification of the abundance of cGAMP level in CGAS−/- U2OS cells that had been stably transfected with GFP, GFP-CGAS, GFP-CGASΔ355-360 or GFP-CGASF357A,V360A, respectively, left untreated or treated with NDZ (300 nM) for 24 h followed by 48-h recovery, and cells were cultured in the absence or presence of CQ (40 μM) for 12 h prior to harvesting. Data are expressed as mean ± (SEM) of n = 3 independent experiments (A, C, D). Data in (B) is representative of n = 3 independent experiments. Two-way ANOVA with Bonferroni post hoc test were used for statistical analysisCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 99 references

Research works printed but not linked: 6

  1. Ipek E, 2017, Anatol J Cardiol, 17, 483
  2. Volkman HE, 2019, Elife
  3. Quezada-Vidal J, Environ Mol Mutagen
  4. Leuchowius KJ, 2011, Curr Protoc Cytom, 56
  5. Jiang H, 2019, Embo J, 38, 10.15252/embj.2019102718 · DOI · Paper page
  6. Liu H, 2019, EMBO Rep, 20

Cited by

See all 89

Metadata

Authors
Zhao, M., Wang, F., Wu, J., Cheng, Y., Cao, Y., Wu, X., Ma, M., Tang, F., Liu, Z., Liu, H., & Ge, B.
Affiliations
  • Tongji University (CN)
  • Viva Biotech (China) (CN)
Corresponding author
Liu, Haipeng
Venue
Autophagy
Published
2021-03-22
Volume
17
Issue
12
Pages
3976-3991
ISSN
  • 1554-8627 (ISSN-L)
  • 1554-8635
OpenAlex
W3138417159
Cited by
89
References
99
Citations by year
2026: 17 · 2025: 14 · 2024: 18 · 2023: 24 · 2022: 12 · 2021: 4
FWCI
10.44
Type
journal article
Language
en
Open access
Locations
  • Autophagy (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
National Natural Science Foundation of China (81922030, 81770006, 91542111, 31030028, 81772465)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Keywords
cGAS, genotoxic stress, LIR motif, cGAMP, innate immune surveillance, genomic instability, DNA sensing, STING
MeSH terms
Autophagy, DNA, Humans, Immunity, Innate, Inflammation, Nucleotidyltransferases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CGAS is a micronucleophagy receptor for the clearance of micronuclei. https://app.cochat.ai/papers/10.1080/15548627.2021.1899440
The paper
Zhao, M., Wang, F., Wu, J., Cheng, Y., Cao, Y., Wu, X., Ma, M., Tang, F., Liu, Z., Liu, H., & Ge, B. (2021). CGAS is a micronucleophagy receptor for the clearance of micronuclei. Autophagy. https://doi.org/10.1080/15548627.2021.1899440

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.